Analysts expect Protara Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 120,145.06 | 166,438.76 | 15.72 M | 16.64 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 101,966.96 | 139,286.12 | 12.97 M | 14.72 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 111,056.01 | 152,862.44 | 14.35 M | 15.68 M |
Analysts expect Protara Therapeutics, Inc. to report earnings per share of -0.39 for Q3 26, against a range of -0.41 to -0.37. The most recent reported quarter, Q2 26, came in at -0.36, a 16.1% miss against the -0.31 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.50 | -0.48 | -0.29 | -0.35 | -0.31 | -0.37 | -0.31 | -0.36 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.52 | -0.49 | -0.43 | -0.33 | -0.34 | -0.28 | -0.33 | -0.30 | -0.37 | -0.34 | -0.47 | -0.47 | -0.41 | -0.36 | -0.16 | -0.21 | ||||||||||
| Low Estimate | -0.58 | -0.57 | -0.49 | -0.41 | -0.38 | -0.32 | -0.37 | -0.32 | -0.41 | -0.42 | -0.51 | -0.57 | -0.49 | -0.42 | -0.18 | -0.23 | ||||||||||
| Consensus Estimate | -0.55 | -0.53 | -0.46 | -0.37 | -0.36 | -0.30 | -0.35 | -0.31 | -0.39 | -0.38 | -0.49 | -0.52 | -0.45 | -0.39 | -0.17 | -0.22 |
Pull Wall Street consensus for Protara Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=TARA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "TARA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=TARA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();